Improving cardiovascular risk stratification through the derivation and validation of an elevated triglyceride-glucose index

Abstract Background and Aims Triglyceride-glucose (TyG) index, is an emerging prognostic biomarker in atherosclerotic cardiovascular disease (ASCVD). Validation of its clinical value and of clinically relevant prognostic cut-off, remains an unmet need to integrate TyG into primary prevention protoco...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Mavraganis, Georgios (VerfasserIn) , Georgiopoulos, Georgios (VerfasserIn) , Athanasopoulos, Stavros (VerfasserIn) , Terentes-Printzios, Dimitrios (VerfasserIn) , Zervas, Georgios (VerfasserIn) , Konstantaki, Christina (VerfasserIn) , Koilakou, Maria Eleni (VerfasserIn) , Giannakopoulou, Sofia-Panagiota (VerfasserIn) , Dimopoulou, Maria-Angeliki (VerfasserIn) , Chrysochoou, Christina (VerfasserIn) , Tsioufis, Konstantinos (VerfasserIn) , Pitsavos, Christos (VerfasserIn) , Liberopoulos, Evangelos (VerfasserIn) , Stellos, Konstantinos (VerfasserIn) , Vlachopoulos, Charalambos (VerfasserIn) , Panagiotakos, Demosthenes (VerfasserIn) , Stamatelopoulos, Kimon (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2025
In: Diabetes, obesity and metabolism
Year: 2025, Pages: 1-12
ISSN:1463-1326
DOI:10.1111/dom.70270
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1111/dom.70270
Verlag, kostenfrei, Volltext: https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.70270
Volltext
Verfasserangaben:Georgios Mavraganis MD, Georgios Georgiopoulos MD, Stavros Athanasopoulos MD, Dimitrios Terentes-Printzios MD, Georgios Zervas MD, Christina Konstantaki MD, Maria Eleni Koilakou MD, Sofia-Panagiota Giannakopoulou MD, Maria-Angeliki Dimopoulou MD, Christina Chrysochoou MD, Konstantinos Tsioufis MD, Christos Pitsavos MD, Evangelos Liberopoulos MD, Konstantinos Stellos MD, Charalambos Vlachopoulos MD, Demosthenes Panagiotakos PhD, Kimon Stamatelopoulos MD

MARC

LEADER 00000naa a22000002c 4500
001 1942157886
003 DE-627
005 20251124152659.0
007 cr uuu---uuuuu
008 251124s2025 xx |||||o 00| ||eng c
024 7 |a 10.1111/dom.70270  |2 doi 
035 |a (DE-627)1942157886 
035 |a (DE-599)KXP1942157886 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Mavraganis, Georgios  |e VerfasserIn  |0 (DE-588)1367510457  |0 (DE-627)192725101X  |4 aut 
245 1 0 |a Improving cardiovascular risk stratification through the derivation and validation of an elevated triglyceride-glucose index  |c Georgios Mavraganis MD, Georgios Georgiopoulos MD, Stavros Athanasopoulos MD, Dimitrios Terentes-Printzios MD, Georgios Zervas MD, Christina Konstantaki MD, Maria Eleni Koilakou MD, Sofia-Panagiota Giannakopoulou MD, Maria-Angeliki Dimopoulou MD, Christina Chrysochoou MD, Konstantinos Tsioufis MD, Christos Pitsavos MD, Evangelos Liberopoulos MD, Konstantinos Stellos MD, Charalambos Vlachopoulos MD, Demosthenes Panagiotakos PhD, Kimon Stamatelopoulos MD 
264 1 |c 2025 
300 |b Diagramme 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Erstmals veröffentlicht: 3. November 2025 
500 |a Gesehen am 24.11.2025 
520 |a Abstract Background and Aims Triglyceride-glucose (TyG) index, is an emerging prognostic biomarker in atherosclerotic cardiovascular disease (ASCVD). Validation of its clinical value and of clinically relevant prognostic cut-off, remains an unmet need to integrate TyG into primary prevention protocols. Methods To assess the clinical applicability of TyG, a composite of cardiovascular mortality, myocardial infarction, coronary revascularization or stroke was used as the primary endpoint in a general population cohort (ATTICA cohort, n?=?1677, derivation cohort). Next, we derived an optimal prognostic TyG cut-off and externally validated it in a primary prevention cohort (n?=?1237). To assess the clinical value of TyG, we analysed 1170 consecutively recruited patients from an ongoing registry aiming to stratify ASCVD risk (Athens Cardiometabolic Cohort) and assessed indices of subclinical arterial injury and progression of atherosclerosis. The TyG index was calculated by the formula: ln[fasting triglycerides (mg/dL)???fasting glucose (mg/dL)/2]. Results TyG index was independently associated with increased CVD events in the derivation cohort (HR?=?1.33, p?=?0.020). The incremental value of a derived optimal cut-off of 8.46 over SCORE2 was confirmed in both derivation and validation cohorts [net reclassification index (NRI)?=?0.668 and 0.469 respectively, Delta Harrell's C index?=?0.054 and 0.044 respectively, p? 
650 4 |a cardiovascular disease 
650 4 |a cohort study 
650 4 |a insulin resistance 
650 4 |a population study 
700 1 |a Georgiopoulos, Georgios  |e VerfasserIn  |4 aut 
700 1 |a Athanasopoulos, Stavros  |e VerfasserIn  |4 aut 
700 1 |a Terentes-Printzios, Dimitrios  |e VerfasserIn  |4 aut 
700 1 |a Zervas, Georgios  |e VerfasserIn  |4 aut 
700 1 |a Konstantaki, Christina  |e VerfasserIn  |4 aut 
700 1 |a Koilakou, Maria Eleni  |e VerfasserIn  |4 aut 
700 1 |a Giannakopoulou, Sofia-Panagiota  |e VerfasserIn  |4 aut 
700 1 |a Dimopoulou, Maria-Angeliki  |e VerfasserIn  |4 aut 
700 1 |a Chrysochoou, Christina  |e VerfasserIn  |4 aut 
700 1 |a Tsioufis, Konstantinos  |e VerfasserIn  |4 aut 
700 1 |a Pitsavos, Christos  |e VerfasserIn  |4 aut 
700 1 |a Liberopoulos, Evangelos  |e VerfasserIn  |4 aut 
700 1 |a Stellos, Konstantinos  |d 1981-  |e VerfasserIn  |0 (DE-588)133214354  |0 (DE-627)538682132  |0 (DE-576)272835803  |4 aut 
700 1 |a Vlachopoulos, Charalambos  |e VerfasserIn  |4 aut 
700 1 |a Panagiotakos, Demosthenes  |e VerfasserIn  |4 aut 
700 1 |a Stamatelopoulos, Kimon  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Diabetes, obesity and metabolism  |d Oxford [u.a.] : Wiley-Blackwell, 1999  |g (2025), Seite 1-12  |h Online-Ressource  |w (DE-627)320440982  |w (DE-600)2004918-3  |w (DE-576)091142679  |x 1463-1326  |7 nnas  |a Improving cardiovascular risk stratification through the derivation and validation of an elevated triglyceride-glucose index 
773 1 8 |g year:2025  |g pages:1-12  |g extent:12  |a Improving cardiovascular risk stratification through the derivation and validation of an elevated triglyceride-glucose index 
856 4 0 |u https://doi.org/10.1111/dom.70270  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.70270  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20251124 
993 |a Article 
994 |a 2025 
998 |g 133214354  |a Stellos, Konstantinos  |m 133214354:Stellos, Konstantinos  |d 60000  |d 65000  |e 60000PS133214354  |e 65000PS133214354  |k 0/60000/  |k 1/60000/65000/  |p 14 
999 |a KXP-PPN1942157886  |e 4812150256 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"noteIll":"Diagramme","extent":"12 S."}],"id":{"eki":["1942157886"],"doi":["10.1111/dom.70270"]},"title":[{"title":"Improving cardiovascular risk stratification through the derivation and validation of an elevated triglyceride-glucose index","title_sort":"Improving cardiovascular risk stratification through the derivation and validation of an elevated triglyceride-glucose index"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"2025","dateIssuedKey":"2025"}],"relHost":[{"recId":"320440982","physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1463-1326"],"eki":["320440982"],"zdb":["2004918-3"],"doi":["10.1111/(ISSN)1463-1326"]},"title":[{"title":"Diabetes, obesity and metabolism","title_sort":"Diabetes, obesity and metabolism"}],"origin":[{"publisherPlace":"Oxford [u.a.] ; Oxford [u.a.] ; Oxford","dateIssuedKey":"1999","dateIssuedDisp":"1999-","publisher":"Wiley-Blackwell ; Blackwell ; Blackwell Science"}],"part":{"text":"(2025), Seite 1-12","pages":"1-12","extent":"12","year":"2025"},"language":["eng"],"note":["Gesehen am 28.10.03"],"pubHistory":["1.1999 -"],"disp":"Improving cardiovascular risk stratification through the derivation and validation of an elevated triglyceride-glucose indexDiabetes, obesity and metabolism","type":{"media":"Online-Ressource","bibl":"periodical"}}],"name":{"displayForm":["Georgios Mavraganis MD, Georgios Georgiopoulos MD, Stavros Athanasopoulos MD, Dimitrios Terentes-Printzios MD, Georgios Zervas MD, Christina Konstantaki MD, Maria Eleni Koilakou MD, Sofia-Panagiota Giannakopoulou MD, Maria-Angeliki Dimopoulou MD, Christina Chrysochoou MD, Konstantinos Tsioufis MD, Christos Pitsavos MD, Evangelos Liberopoulos MD, Konstantinos Stellos MD, Charalambos Vlachopoulos MD, Demosthenes Panagiotakos PhD, Kimon Stamatelopoulos MD"]},"language":["eng"],"note":["Erstmals veröffentlicht: 3. November 2025","Gesehen am 24.11.2025"],"recId":"1942157886","person":[{"display":"Mavraganis, Georgios","given":"Georgios","family":"Mavraganis","role":"aut"},{"display":"Georgiopoulos, Georgios","given":"Georgios","role":"aut","family":"Georgiopoulos"},{"given":"Stavros","display":"Athanasopoulos, Stavros","role":"aut","family":"Athanasopoulos"},{"role":"aut","family":"Terentes-Printzios","display":"Terentes-Printzios, Dimitrios","given":"Dimitrios"},{"role":"aut","family":"Zervas","display":"Zervas, Georgios","given":"Georgios"},{"display":"Konstantaki, Christina","given":"Christina","family":"Konstantaki","role":"aut"},{"role":"aut","family":"Koilakou","given":"Maria Eleni","display":"Koilakou, Maria Eleni"},{"family":"Giannakopoulou","role":"aut","display":"Giannakopoulou, Sofia-Panagiota","given":"Sofia-Panagiota"},{"role":"aut","family":"Dimopoulou","given":"Maria-Angeliki","display":"Dimopoulou, Maria-Angeliki"},{"given":"Christina","display":"Chrysochoou, Christina","family":"Chrysochoou","role":"aut"},{"display":"Tsioufis, Konstantinos","given":"Konstantinos","role":"aut","family":"Tsioufis"},{"given":"Christos","display":"Pitsavos, Christos","family":"Pitsavos","role":"aut"},{"given":"Evangelos","display":"Liberopoulos, Evangelos","family":"Liberopoulos","role":"aut"},{"role":"aut","family":"Stellos","given":"Konstantinos","display":"Stellos, Konstantinos"},{"given":"Charalambos","display":"Vlachopoulos, Charalambos","family":"Vlachopoulos","role":"aut"},{"display":"Panagiotakos, Demosthenes","given":"Demosthenes","family":"Panagiotakos","role":"aut"},{"family":"Stamatelopoulos","role":"aut","given":"Kimon","display":"Stamatelopoulos, Kimon"}]} 
SRT |a MAVRAGANISIMPROVINGC2025